Steven E. Arnold, MD
Department of Neurology, Massachusetts General Hospital, Boston; Harvard Medical School, Boston, Massachusetts
Rounds in the General Hospital
Mild Cognitive Impairment and Early Alzheimer’s Disease Management and the Role of New Treatments
November 28, 2023
Monoclonal antibodies have shown some promise for slowing cognitive decline and adverse brain changes in mild cognitive impairment and early Alzheimer’s disease, though risks and anticipated benefits will be...
